| Literature DB >> 28381604 |
Enrique Zozaya-Valdés1, Jessica L Porter1, John Coventry2, Janet A M Fyfe3, Glen P Carter1, Anders Gonçalves da Silva2, Mark B Schultz2, Torsten Seemann4, Paul D R Johnson5, Andrew J Stewardson5, Ivan Bastian6, Sally A Roberts7, Benjamin P Howden2,8, Deborah A Williamson2, Timothy P Stinear9,8.
Abstract
Mycobacterium chimaera is an opportunistic environmental mycobacterium belonging to the Mycobacterium avium-M. intracellulare complex. Although most commonly associated with pulmonary disease, there has been growing awareness of invasive M. chimaera infections following cardiac surgery. Investigations suggest worldwide spread of a specific M. chimaera clone, associated with contaminated hospital heater-cooler units used during the surgery. Given the global dissemination of this clone, its potential to cause invasive disease, and the laboriousness of current culture-based diagnostic methods, there is a pressing need to develop rapid and accurate diagnostic assays specific for M. chimaera Here, we assessed 354 mycobacterial genome sequences and confirmed that M. chimaera is a phylogenetically coherent group. In silico comparisons indicated six DNA regions present only in M. chimaera We targeted one of these regions and developed a TaqMan quantitative PCR (qPCR) assay for M. chimaera with a detection limit of 100 CFU/ml in whole blood spiked with bacteria. In vitro screening against DNA extracted from 40 other mycobacterial species and 22 bacterial species from 21 diverse genera confirmed the in silico-predicted specificity for M. chimaera Screening 33 water samples from heater-cooler units with this assay highlighted the increased sensitivity of PCR compared to culture, with 15 of 23 culture-negative samples positive by M. chimaera qPCR. We have thus developed a robust molecular assay that can be readily and rapidly deployed to screen clinical and environmental specimens for M. chimaera.Entities:
Keywords: diagnostics; genomics; infectious disease; mycobacterium
Mesh:
Substances:
Year: 2017 PMID: 28381604 PMCID: PMC5442541 DOI: 10.1128/JCM.00197-17
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948